Saroglitazar, a Dual PPAR &#945;/Î³ Agonist, Improves Atherogenic Dyslipidemia in Patients With Non-Cirrhotic Nonalcoholic Fatty Liver Disease: A Pooled Analysis.

Siddiqui, Mohammad Shadab; Parmar, Deven; Sheikh, Farheen; Sarin, Shiv Kumar; Cisneros, Laura; Gawrieh, Samer; Momin, Taufik; Duseja, Ajay; Sanyal, Arun J

Saroglitazar, a Dual PPAR α/Î³ Agonist, Improves Atherogenic Dyslipidemia in Patients With Non-Cirrhotic Nonalcoholic Fatty Liver Disease: A Pooled Analysis.

Siddiqui, Mohammad Shadab; Parmar, Deven; Sheikh, Farheen; Sarin, Shiv Kumar; Cisneros, Laura; Gawrieh, Samer; Momin, Taufik; Duseja, Ajay; Sanyal, Arun J.

Affiliation

Siddiqui MS; Virginia Commonwealth University, Richmond, Virginia. Electronic address: mohammad.siddiqui@vcuhealth.org.
Parmar D; Zydus Therapeutics Inc USA, Pennington, NJ. Electronic address: dparmar@zydustherapeutics.com.
Sheikh F; Zydus Therapeutics Inc USA, Pennington, NJ.
Sarin SK; Department of Hepatology, Institute of Liver & Biliary Sciences, New Delhi, India.
Cisneros L; Christus Muguerza Alta Especialidad, Monterrey, Mexico.
Gawrieh S; Indiana University School of Medicine, Indianapolis, Indiana.
Momin T; Zydus Therapeutics Inc USA, Pennington, NJ.
Duseja A; Postgraduate Institute of Medical Education & Research, Chandigarh, India.
Sanyal AJ; Virginia Commonwealth University, Richmond, Virginia.

Clin Gastroenterol Hepatol ; 21(10): 2597-2605.e2, 2023 09.

Article in En | MEDLINE | ID: mdl-36731585

Subject(s)

Diabetes Mellitus, Type 2; Dyslipidemias; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Non-alcoholic Fatty Liver Disease; Humans; Non-alcoholic Fatty Liver Disease/complications; Non-alcoholic Fatty Liver Disease/drug therapy; Diabetes Mellitus, Type 2/drug therapy; PPAR alpha/agonists; PPAR alpha/therapeutic use; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; PPAR-gamma Agonists; Dyslipidemias/complications; Dyslipidemias/drug therapy; Triglycerides; Cholesterol

Key words

Cardiovascular Disease; Lipids; Nonalcoholic Steatohepatitis; Saroglitazar; Small Dense LDL

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Diabetes Mellitus, Type 2 / Dyslipidemias / Non-alcoholic Fatty Liver Disease / Hypertension Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: Clin Gastroenterol Hepatol Journal subject: GASTROENTEROLOGIA Year: 2023 Type: Article

Fulltext

XML

PubMed Links

Search on Google